[Anti-amebic effects of aureomycin, terramycin, and fumagillin in vivo].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002751:Chlortetracycline / Q000627:therapeutic use*; D003510:Cyclohexanes; D004404:Dysentery, Amebic / Q000628:therapy*; D005231:Fatty Acids, Unsaturated; D010118:Oxytetracycline / Q000627:therapeutic use*; D012717:Sesquiterpenes
D000900:Anti-Bacterial Agents; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; C026211:fumagillin; D002751:Chlortetracycline; D010118:Oxytetracycline
AMEBIASIS, INTESTINAL/therapy; ANTIBIOTICS/therapeutic use; CHLORTETRACYCLINE/therapeutic use; OXYTETRACYCLINE/therapeutic use
Efectos amebicidas in vivo de la aureomicina, terramicina y fumagilina.